title: Inducible nitric oxide synthase inhibition attenuates physical stress-induced lung hyper-responsiveness and oxidative stress in animals with lung inflammation.
abstract: Mechanisms involved in stress-induced asthmatic alterations have been poorly characterised. We assessed whether inducible nitric oxide synthase (iNOS) inhibition modulates the stress-amplified lung parenchyma responsiveness, oxidative stress and extracellular matrix remodelling that was previously increased by chronic lung inflammation. Guinea pigs were subjected to 7 exposures to ovalbumin (1-5 mg/ml) or saline (OVA and SAL groups) over 4 weeks. To induce behavioural stress, animals were subjected to a forced swimming protocol (5 times/week, over 2 weeks; SAL-Stress and OVA-Stress groups) 24 h after the 4th inhalation. 1400W (iNOS-specific inhibitor) was administered intraperitoneally in the last 4 days of the protocol (SAL-1400W, OVA-1400W, SAL-Stress+1400W and OVA-Stress+1400W groups). Seventy-two hours after the last inhalation, animals were anaesthetised and exsanguinated, and adrenal glands were removed. Lung tissue resistance and elastance were evaluated by oscillatory mechanics and submitted for histopathological evaluation. Stressed animals had higher adrenal weights compared to non-stressed groups, which were reduced by 1400W treatment. Behavioural stress in sensitised animals amplified the resistance and elastance responses after antigen challenge, numbers of eosinophils and iNOS+ cells, actin content and 8-iso-PGF2α density in the distal lung compared to the OVA group. 1400W treatment in ovalbumin-exposed and stressed animals reduced lung mechanics, iNOS+ cell numbers and 8-iso-PGF2α density compared to sensitised and stressed animals that received vehicle treatment. We concluded that stress amplifies the distal lung constriction, eosinophilic inflammation, iNOS expression, actin content and oxidative stress previously induced by chronic lung inflammation. iNOS-derived NO contributes to stress-augmented lung tissue functional alterations in this animal model and is at least partially due to activation of the oxidative stress pathway.
authors.affiliation: Departamento de Clínica Médica, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brasil.
authors.forename: Ricardo Henrique
authors.initials: RH
authors.lastname: Marques
authors.forename: Fabiana G
authors.initials: FG
authors.lastname: Reis
authors.forename: Claudia M
authors.initials: CM
authors.lastname: Starling
authors.forename: Claudia
authors.initials: C
authors.lastname: Cabido
authors.forename: Rafael
authors.initials: R
authors.lastname: de Almeida-Reis
authors.forename: Marisa
authors.initials: M
authors.lastname: Dohlnikoff
authors.forename: Carla M
authors.initials: CM
authors.lastname: Prado
authors.forename: Edna A
authors.initials: EA
authors.lastname: Leick
authors.forename: Mílton A
authors.initials: MA
authors.lastname: Martins
authors.forename: Iolanda F L C
authors.initials: IF
authors.lastname: Tibério
mesh_terms: D000199:Actins / Q000378:metabolism; D000311:Adrenal Glands / Q000473:pathology; D000818:Animals; D003094:Collagen; D015237:Dinoprost / Q000031:analogs & derivatives / Q000378:metabolism; D004804:Eosinophils / Q000473:pathology; D006168:Guinea Pigs; D006854:Hydrocortisone / Q000097:blood; D008168:Lung / Q000201:enzymology / Q000276:immunology / Q000473:pathology; D008297:Male; D052247:Nitric Oxide Synthase Type II / Q000008:administration & dosage* / Q000037:antagonists & inhibitors* / Q000502:physiology*; D009929:Organ Size; D018384:Oxidative Stress; D011014:Pneumonia / Q000201:enzymology* / Q000473:pathology / Q000503:physiopathology; D013312:Stress, Physiological
chemical_list: D000199:Actins; C075750:8-epi-prostaglandin F2alpha; D003094:Collagen; D015237:Dinoprost; D052247:Nitric Oxide Synthase Type II; D006854:Hydrocortisone